%0 Journal Article
%T Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?
%A Anna Jagicza
%A Bal¨¢zs N¨¦meth
%A Imre Boncz
%A Istv¨¢n Kiss
%A Iv¨¢n G Horv¨¢th
%A Iv¨¢n P¨¦ter
%A P¨¦ter Kust¨¢n
%A Tam¨¢s K£¿szegi
%A Z¨¦n¨® Ajtay
%A ¨¢gnes Cserg£¿
%J Archive of "Therapeutics and Clinical Risk Management".
%D 2019
%R 10.2147/TCRM.S197633
%X Psoriasis is one of the most common lifelong lasting dermatologic diseases. According to the latest studies, psoriatic patients have a higher risk of developing cardiovascular diseases. Psoriasis is considered as a systemic inflammatory disease. Several oxidative stress markers have been shown to be elevated in psoriasis. However, a panel of biomarkers has not been used yet. This study was aimed at exploring the connection between a panel of biomarkers (C-reactive protein, asymmetric dimethylarginine, uric acid, total antioxidant capacity, malondialdehyde, and orosomucoid [ORM]) and cardiovascular risk in psoriatic patients
%K psoriasis
%K orosomucoid
%K oxidative stress
%K C-reactive protein
%K biomarker
%K cardiovascular risk
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616299/